Memantine for Patients with Alzheimer Disease [1] (multiple letters)

JAMA

Volumn 291, Issue 14, 2004, Pages 1695-

  Finucane, Thomas E ^a   Tariot, Pierre N ^b  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; MEMANTINE; NOOTROPIC AGENT; PLACEBO; AMINO ACID RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE;

ALZHEIMER DISEASE; CAREGIVER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG INDICATION; HUMAN; LETTER; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; NOTE;

ALZHEIMER DISEASE; CAREGIVERS; CHOLINESTERASE INHIBITORS; COST-BENEFIT ANALYSIS; DOPAMINE AGENTS; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; INDANS; MEMANTINE; NOOTROPIC AGENTS; PIPERIDINES; QUALITY OF LIFE;

EID: 1842845103     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.14.1695-a     Document Type: Letter

References (0)